LP18087-4

OLANZapine

Active

Descriptions

Olanzapine is similar in chemical structure and in mechanism of action to clozapine (Clozaril). It works by blocking receptors on the nerves of the brain for several neurotransmitters, and it binds to alpha-1, dopamine, histamine H-1, muscarinic, and serotonin type 2 (5-HT2) receptors. It is used to treat schizophrenia and acute manic episodes associated with the bipolar 1 disorder. Source: Regenstrief Institute

Olanzapine (brand name Zyprexa) is an atypical antipsychotic used to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. It works by changing the activity of certain natural substances in the brain. Olanzapine is not approved by the Food and Drug Administration (FDA) for the treatment of behavior disorders in older adults with dementia as there is an increased risk of stroke and death during treatment. Source: Regenstrief LOINC, MedlinePlus: a601213

Basic Part Properties

Part Display Name

OLANZapine

Part Type

Component (Describes the core component or analyte measured)

Created On

2000-05-04

Construct for LOINC Short Name

OLANZapine

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP18087-4

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP18087-4

Language Variants Get Info

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.